Why Alkermes' Q4 Results Were Better Than They Might Seem

Alkermes (NASDAQ:ALKS) proved to be a disappointment for investors last year, with its stock slipping while the overall market soared. However, the biotech is off to a pretty good start in 2021.

That good start isn't as strong as it was. Alkermes announced its fourth-quarter results before the market opened on Thursday. Its shares slid more than 8% in early trading. Here are the highlights of the biotech's Q4 update.